Actavis Albuterol Inhaler Recall: Impurities May Cause Harm
Actavis recalls Albuterol Sulfate Inhalation Solution vials due to impurities. This medication may cause harm if used as intended. Affected vials have specific lot numbers and expiration dates.
Recall notice
Failed Impurities/Degradation Specifications: Product is out of specification for a known degradant.
Contact the company
What happened, in plain English
Actavis is recalling Albuterol Sulfate Inhalation Solution vials that may contain impurities. Using these vials could lead to health risks, so affected users should stop using them and contact their doctor. Read more at govinfonow.com/recall/42090-actavis-albuterol-inhaler-recall-impurities-may-cause-harm.
Source Summary by GovInfoNow · govinfonow.com/recall/42090-actavis-albuterol-inhaler-recall-impurities-may-cause-harm · Updated October 8, 2026 · FDA enforcement record: FDA #D-0439-2017
Cite this page
“Actavis Albuterol Inhaler Recall: Impurities May Cause Harm.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/42090-actavis-albuterol-inhaler-recall-impurities-may-cause-harm. Based on FDA recall #D-0439-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0439-2017%22&limit=1).
Why it’s dangerous
The product failed impurities and degradation specifications. This means the medication may contain harmful substances that could cause health issues if used as intended.
Who’s affected
People with a prescription for this medication from Watson Laboratories. Those using the product without a prescription are not affected.
How to tell if you have this one
Check for vials labeled 'Albuterol Sulfate Inhalation Solution, USP, 0.021% (0.63 mg / 3 mL), 3mL'. The lot numbers listed are GA51265 through GA51749 with specific expiration dates.
- Brand
Actavis- Category
Drug
What to do — step by step
Check Product Details
Look for the lot numbers GA51265, GA51454, GA51553, GA51583, GA51598, GA51724, GA51725, or GA51749 on the vial.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the US” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 14 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
What should I do if I have the recalled product?
Contact your doctor for advice on what to do next.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0439-2017 (January 12, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0439-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.